# SR Bancorp, Inc.: overview SRBK · Nasdaq · CIK 1951276 · [Financials](/sectors/financials.md) · fiscal year ends Jun 30 Pages: [Overview](/companies/srbk.md) · [Financials](/companies/srbk/financials.md) · [Filings](/companies/srbk/filings.md) · [Insiders](/companies/srbk/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q1 FY2025 (2024-09-30) | Q2 FY2025 (2024-12-31) | Q3 FY2025 (2025-03-31) | Q4 FY2025 (2025-06-30) | Q1 FY2026 (2025-09-30) | Q2 FY2026 (2025-12-31) | Q3 FY2026 (2026-03-31) | Q4 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.16](/filings/0001193125-25-282845.md) | [0.12](/filings/0001193125-26-051277.md) | [0.06](/filings/0001437749-26-017364.md) | not reported | [0.09](/filings/0001193125-25-282845.md) | [0.11](/filings/0001193125-26-051277.md) | [0.12](/filings/0001437749-26-017364.md) | not reported | | Free cash flow | $k | [1,707](/filings/0001193125-25-282845.md) | [(1,533) d](/filings/0001193125-26-051277.md) | [2,497 d](/filings/0001437749-26-017364.md) | [1,561 d](/filings/0001437749-26-031222.md) | [1,146](/filings/0001193125-25-282845.md) | [3,098 d](/filings/0001193125-26-051277.md) | [1,876 d](/filings/0001437749-26-017364.md) | [3,763 d](/filings/0001437749-26-031222.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 6-month figure less the 3-month figure; 9-month figure less the 6-month figure; 12-month figure less the 9-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-06-30) | FY2023 (2023-06-30) | FY2024 (2024-06-30) | FY2025 (2025-06-30) | FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | not reported | not reported | [(1.59)](/filings/0001193125-25-223165.md) | [0.61](/filings/0001437749-26-031222.md) | [0.44](/filings/0001437749-26-031222.md) | | Free cash flow | $k | [708](/filings/0000950170-23-050475.md) | [1,804](/filings/0000950170-24-114772.md) | [(2,841)](/filings/0001193125-25-223165.md) | [4,232](/filings/0001437749-26-031222.md) | [9,883](/filings/0001437749-26-031222.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/srbk/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $9.8m | 497,081 | | Added +38,128 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $5.9m | 298,855 | | Reduced −68,101 | | [Saber Capital Managment, LLC](/funds/1911378.md) | 2026-06-30 | $4.1m | 208,552 | | Reduced −24,447 | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $3.5m | 176,000 | | Reduced −4,300 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $3.4m | 170,842 | | Added +8,397 | | [MANGROVE PARTNERS IM, LLC](/funds/1535392.md) | 2026-06-30 | $3.4m | 170,402 | | Unchanged | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $2.9m | 144,961 | | Added +53,857 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $1.6m | 81,842 | | Reduced −1,444 | | [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $1.1m | 54,301 | | Added +3,951 | | [Covalent Partners LLC](/funds/1531611.md) | 2026-03-31 | $1.0m | 60,000 | | Not compared | ## Recent filings [All 165 filings](/companies/srbk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-26 | 16:00 ET | [8-K](/filings/0001437749-26-033517.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033517 | | 2026-10-19 | 09:20 ET | [DEF 14A](/filings/0001193125-26-424753.md) | Proxy statement, period 2026-11-18 | 0001193125-26-424753 | | 2026-09-25 | 16:01 ET | [10-K](/filings/0001437749-26-031222.md) | Annual report, period 2026-06-30 | 0001437749-26-031222 | | 2026-09-17 | 16:15 ET | [8-K](/filings/0000943374-26-000413.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000943374-26-000413 | | 2026-07-28 | 16:00 ET | [8-K](/filings/0001437749-26-024660.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024660 | | 2026-07-10 | 16:29 ET | [8-K](/filings/0000943374-26-000261.md) | 8.01 Other events | 0000943374-26-000261 | | 2026-06-18 | 10:03 ET | [8-K](/filings/0000943374-26-000231.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000943374-26-000231 | | 2026-05-21 | 16:15 ET | [8-K](/filings/0000943374-26-000207.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0000943374-26-000207 | | 2026-05-15 | 16:01 ET | [10-Q](/filings/0001437749-26-017364.md) | Quarterly report, period 2026-03-31 | 0001437749-26-017364 | | 2026-04-28 | 16:01 ET | [8-K](/filings/0001437749-26-013637.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-013637 | ## Latest annual report [Form 10-K for the fiscal year ended Jun 30, 2026](/filings/0001437749-26-031222.md), filed Sep 25, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1951276 - Tickers: SRBK - Exchange: Nasdaq - SIC code: 6036 Savings Institutions, Not Federally Chartered - State of incorporation: MD - Filer category: Non-accelerated filer
Smaller reporting company
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 16:02 ET. No prices; not investment advice.